Status:
COMPLETED
Impact of Pollution on Allergic Rhinitis and Sleep Quality: the POLLAR Study
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Sleep Apnea
Allergic Rhinitis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
It has been demonstrated that allergic rhinitis (AR) reduces sleep quality by some components such as nasal obstruction. Pollution and allergen exposure worsening AR, sleep quality is deteriorated. S...
Detailed Description
Over 150 million people have allergic rhinitis (AR) in Europe and around 30% have uncontrolled AR during allergen exposure. It has been demonstrated that AR reduces sleep quality by some components su...
Eligibility Criteria
Inclusion
- 18-65 years
- Be able to use an application on a personal smartphone
- Patient non treated for OSA
- Be legally able to give consent
- Person affiliated to social security
Exclusion
- \- Being unable to understand, follow objectives and methods due to cognition or language problems Subjects listed in articles L1121-5 à L1121-8: Pregnant women, feeding and parturient; subject under administrative or judicial control, persons who are protected under the act.
Key Trial Info
Start Date :
April 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 25 2020
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT03776773
Start Date
April 8 2019
End Date
January 25 2020
Last Update
March 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Grenoble
Grenoble, France